NovaQuest Capital Management
NovaQuest Capital Management, LLC, established in 2010 and headquartered in Raleigh, North Carolina, is a private equity firm specializing in the global healthcare industry. The company primarily focuses on structured finance investments in late-stage clinical and commercialized biopharmaceutical products, aligning with biopharmaceutical companies on their most strategic product programs. Additionally, NovaQuest invests in select private equity and other company securities, maintaining a consistent focus on late-stage products. With a team that has worked together for over a decade and a track record of investing over $1 billion, NovaQuest offers a customized approach to investment and return elements, meeting the evolving needs of global healthcare companies and their investors.
Clinical Ink
Private Equity Round in 2018
Clinical Ink, Inc. specializes in providing eSource and patient engagement solutions designed to streamline clinical research for sites, sponsors, contract research organizations (CROs), and patients. Founded in 2006 and headquartered in Horsham, Pennsylvania, with additional offices in Winston-Salem and Cary, North Carolina, Philadelphia, Pennsylvania, and Cambridge, Massachusetts, the company offers a suite of innovative tools including SureSource, an electronic source platform that captures data and documents at the site level, and Lunexis ePRO+, which facilitates patient participation in studies. Additionally, Clinical Ink provides CentrosHealth, a patient engagement platform that includes configurable apps to enhance patient involvement and compliance throughout clinical trials. The company aims to improve clinical trial workflows by integrating electronic data capture and reducing manual processes, ensuring that clients have access to high-quality, validated data.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.